As an emerging biomarker for inflammatory diseases, the level of S100A12 in serum can reflect the systemic inflammatory status in acute otitis media, cystic fibrosis, respiratory distress syndrome, and dermatomyositis-associated interstitial lung disease [67, 68]. This evidence concerns the gene S100A12 and cystic fibrosis.